Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 9,736,000 | 9,879,000 | 8,438,000 | 9,316,000 | 10,017,000 |
| Cost of Goods | 3,438,000 | 3,176,000 | 2,678,000 | 2,865,000 | 3,457,000 |
| Gross Profit | 6,298,000 | 6,703,000 | 5,760,000 | 6,451,000 | 6,560,000 |
| Operating Expenses | 4,636,000 | 4,089,000 | 4,208,000 | 4,386,000 | 5,003,000 |
| Operating Income | 1,662,000 | 2,614,000 | 1,552,000 | 2,065,000 | 1,557,000 |
| Interest Expense | 147,000 | 91,000 | 100,000 | 98,000 | 91,000 |
| Other Income | -100,000 | -75,000 | 6,518,000 | 4,000 | -1,658,000 |
| Pre-tax Income | 1,415,000 | 2,448,000 | 7,970,000 | 1,971,000 | -192,000 |
| Income Tax | 329,000 | 490,000 | 560,000 | 434,000 | -142,000 |
| Net Income Continuous | 1,090,000 | 1,959,000 | 7,606,000 | 1,695,000 | -2,000 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | -1,000 |
| Minority Interests | -9,000 | -7,000 | -8,000 | -12,000 | -7,000 |
| Net Income | $1,081,000 | $1,952,000 | $7,598,000 | $1,683,000 | $-10,000 |
| EPS Basic Total Ops | 0.86 | 1.55 | 6.06 | 1.35 | -0.01 |
| EPS Basic Continuous Ops | 0.86 | 1.55 | 6.07 | 1.35 | -0.01 |
| EPS Diluted Total Ops | 0.86 | 1.55 | 6.05 | 1.35 | -0.01 |
| EPS Diluted Continuous Ops | 0.86 | 1.55 | 6.05 | 1.35 | -0.01 |
| EBITDA(a) | $1,956,000 | $2,943,000 | $8,496,000 | $2,526,000 | $409,000 |